Prostate cancer genetics study in Native Americans
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This study looks at the genes of prostate cancer in Native American people. It aims to learn more about the disease in this population by testing stored tumor samples. You can join if you have a prostate cancer diagnosis and have a tumor sample available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as Native American or Alaska Native.
- You have been diagnosed with prostate cancer (any stage).
- You have a stored tumor sample from a past biopsy or surgery that can be tested.
- You are 18 years old or older.
- You are willing to sign a consent form allowing the study to use your medical information and tissue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from people with prostate cancer to better understand how genetics and treatments affect survival and outcomes. Your data may help researchers improve future treatment choices.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial uses genetic test results from your prostate cancer to guide treatment choices. It may help find therapies that better match the specific gene changes in your cancer.
This study offers genetic testing and counseling to African American cancer survivors. It aims to see if a culturally tailored approach helps more people understand their cancer risk and get the testing they need.
This trial studies whether a risk assessment can better predict who actually has prostate cancer based on information collected around the biopsy. It may help doctors decide what biopsy findings mean for people with certain PSA (a blood test) results.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.